NCT01964300 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT01964300
Title	Peginterferon Alfa-2b in Treating Younger Patients With Craniopharyngioma That is Recurrent or Cannot Be Removed By Surgery
Recruitment	Terminated
Gender	both
Phase	Phase II
Variant Requirements	No
Sponsors	Pediatric Brain Tumor Consortium
Indications	craniopharyngioma
Therapies	Peginterferon alfa-2b
Age Groups:	child
Covered Countries	USA

Filter rows:

Showing 1 to 9 of 9 entries

Facility	City	State	Zip	Country	Details
Children Hospital of Pittsburgh of UPMC	Pittsburgh	Pennsylvania	15224	United States	Details
Children's Hospital Los Angeles	Los Angeles	California	90027	United States	Details
Children's National Medical Center	Washington	District of Columbia	20010	United States	Details
Lurie Children's Hospital	Chicago	Illinois	60614	United States	Details
Memorial Sloan Kettering Cancer Center	New York	New York	10065	United States	Details
National Cancer Institute Pediatric Oncology Branch	Bethesda	Maryland	20892	United States	Details
St. Jude Children Research Hospital	Memphis	Tennessee	38105	United States	Details
Stanford University and Lucile Packard Children Hospital	Palo Alto	California	94304	United States	Details
Texas Children's Hospital	Houston	Texas	77030	United States	Details

Showing 1 to 9 of 9 entries

Filter rows:

*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field

NCT01964300Clinical Trial Detail